Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anteris Technologies Global Corp.AVR · Entity 5089 | Director | June 07, 2026 | June 10, 2026 |
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director · President and Director | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anteris Technologies Global Corp.
Report date June 07, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,580 |
Reported balance
After 2026-06-07 transaction · row 1
1 source rowRow 1 · 2026-06-07 · Exercise / conversion · Acquired 17,580 · Balance 17,580 F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 35,162 |
Reported balance
After 2026-06-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-07 · Exercise / conversion · Disposed 17,580 · Balance 35,162 F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis. F2: On December 3, 2025, the reporting person was granted 52,742 RSUs that generally vest in approximately equal installments on June 7, 2026, June 7, 2027 and June 7, 2028, subject to the Reporting Person's continued service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis.
F2: On December 3, 2025, the reporting person was granted 52,742 RSUs that generally vest in approximately equal installments on June 7, 2026, June 7, 2027 and June 7, 2028, subject to the Reporting Person's continued service through each vesting date.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 25.4682 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 25.4682 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 24.7852 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 24.7852 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 30.34 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 3.6322 · Balance 30.34 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 32.3815 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 4.3524 · Balance 32.3815 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 17.5403 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 3.1566 · Balance 17.5403 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 18.6239 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 3.5757 · Balance 18.6239 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 1.9861 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 0.3056 · Balance 1.9861 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 2.0893 |
Reported balance
After 2026-09-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-09-03 · Grant · Acquired 0.3453 · Balance 2.0893 F8: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 13.6627 |
Reported balance
After 2026-09-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-09-03 · Grant · Acquired 5.2874 · Balance 13.6627 F9: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F8: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F9: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2024 Filed Aug 15, 2024 22:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,941 | $35.48 | $104,346.68 |
DisclosureSEC source: 0001437749-24-027053 · rdgdoc.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 13, 2024 Filed Aug 15, 2024 22:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 122 | $23.56 | $2,874.32 |
DisclosureSEC source: 0001437749-24-027053 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.6567 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019065 · rdgdoc.xml · derivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10.1707 Underlying: Common Stock · 4.6567 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.0868 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019065 · rdgdoc.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28.9853 Underlying: Common Stock · 4.0868 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.0868 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019065 · rdgdoc.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29.6683 Underlying: Common Stock · 4.0868 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.6743 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019065 · rdgdoc.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34.3451 Underlying: Common Stock · 2.6743 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.4054 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019065 · rdgdoc.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24.9903 Underlying: Common Stock · 1.4054 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:58 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.746 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019065 · rdgdoc.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17.8327 Underlying: Common Stock · 0.746 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:35 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 5,025 | $75.62 | $379,990.50 |
DisclosureSEC source: 0001437749-24-015383 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,114 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $75.475 to $75.91. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5.514 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010420 · rdgdoc.xml · derivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.514 Underlying: Common Stock · 5.514 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.8393 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010420 · rdgdoc.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24.8985 Underlying: Common Stock · 4.8393 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.8393 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010420 · rdgdoc.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25.5815 Underlying: Common Stock · 4.8393 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.1666 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010420 · rdgdoc.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31.6708 Underlying: Common Stock · 3.1666 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.6648 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010420 · rdgdoc.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23.5849 Underlying: Common Stock · 1.6648 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8836 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010420 · rdgdoc.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17.0867 Underlying: Common Stock · 0.8836 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 6.683 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006507 · rdgdoc.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20.0592 Underlying: Common Stock · 6.683 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 196 | $70.00 | $13,720.00 |
DisclosureSEC source: 0001437749-24-006507 · rdgdoc.xml · nonDerivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,139 F4 · shares: These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006507 · rdgdoc.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:03 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 2,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006507 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,329 F1 · shares: These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years. F2 · price: Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:52 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,244 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001437749-24-004390 · rdgdoc.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122 Underlying: Common Stock · 4,244 shares Expires 2025-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:52 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004390 · rdgdoc.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares from the release of fractional dividend equivalent rights returned to company. F2 · price: Represents shares from the release of fractional dividend equivalent rights returned to company. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:52 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 4,244 | $23.56 | $99,988.64 |
DisclosureSEC source: 0001437749-24-004390 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 00:47 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-035161 · rdgdoc.xml · derivative · entry 8 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16.2031 Underlying: Common Stock · 15 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/20/2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/20/2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/20/2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/20/2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 00:47 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 169 | $54.85 | $9,269.65 |
DisclosureSEC source: 0001437749-23-035161 · rdgdoc.xml · nonDerivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,438 F4 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/20/2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 00:47 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-035161 · rdgdoc.xml · nonDerivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 00:47 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-035161 · rdgdoc.xml · derivative · entry 7 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/19/2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/19/2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/19/2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/19/2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 00:47 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-035161 · rdgdoc.xml · derivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.5479 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/19/2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/19/2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/19/2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/19/2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 00:47 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-035161 · rdgdoc.xml · nonDerivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares acquired from the release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F2 · price: Represents shares acquired from the release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 00:47 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 253 | $56.06 | $14,183.18 |
DisclosureSEC source: 0001437749-23-035161 · rdgdoc.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,590 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/19/2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 19, 2023 Filed Dec 22, 2023 00:47 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-035161 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 22:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034359 · rdgdoc.xml · derivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20.7422 Underlying: Common Stock · 6 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 22:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 296 | $53.81 | $15,927.76 |
DisclosureSEC source: 0001437749-23-034359 · rdgdoc.xml · nonDerivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,810 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 22:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034359 · rdgdoc.xml · nonDerivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034359 · rdgdoc.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28.5042 Underlying: Common Stock · 14 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 292 | $54.40 | $15,884.80 |
DisclosureSEC source: 0001437749-23-034359 · rdgdoc.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,100 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/11/2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034359 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 22:20 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 11,996 | $0.00 Strike: $54.65 | $0.00 |
DisclosureSEC source: 0001437749-23-034234 · rdgdoc.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,996 Underlying: Common Stock · 11,996 shares Expires 2030-12-08 F2 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 22:20 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 2,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034234 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,378 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| December 02, 2023 Filed Dec 5, 2023 21:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033647 · rdgdoc.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21.9201 Underlying: Common Stock · 8 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 02, 2023 Filed Dec 5, 2023 21:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 155 | $53.83 | $8,343.65 |
DisclosureSEC source: 0001437749-23-033647 · rdgdoc.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,091 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 2, 2020. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 02, 2023 Filed Dec 5, 2023 21:10 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033647 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 7.0895 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033495 · rdgdoc.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26.74 Underlying: Common Stock · 7.0895 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5.2213 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033495 · rdgdoc.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42.5 Underlying: Common Stock · 5.2213 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.7425 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033495 · rdgdoc.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29.92 Underlying: Common Stock · 2.7425 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.9483 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033495 · rdgdoc.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31.2 Underlying: Common Stock · 1.9483 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:01 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.4966 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-033495 · rdgdoc.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35.55 Underlying: Common Stock · 1.4966 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/19/2018 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 19:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 6.4469 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025161 · rdgdoc.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19.6527 Underlying: Common Stock · 6.4469 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 19:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.7481 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025161 · rdgdoc.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37.2829 Underlying: Common Stock · 4.7481 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 19:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.4933 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025161 · rdgdoc.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27.1776 Underlying: Common Stock · 2.4933 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 19:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.7708 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-025161 · rdgdoc.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29.2548 Underlying: Common Stock · 1.7708 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.